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Abstract 
Background: Expansion of aquaculture is seriously limited by reductions in fish oil (FO) 
supply for aquafeeds. Terrestrial alternatives such as vegetable oils (VO) have been 
investigated and recently a strategy combining genetic selection with changes in diet 
formulations has been proposed to meet growing demands for aquaculture products. This 
study investigates the influence of genotype on transcriptomic responses to sustainable feeds 
in Atlantic salmon.  
Results: A microarray analysis was performed to investigate the liver transcriptome of two 
family groups selected according to their estimated breeding values (EBVs) for flesh lipid 
content, 'Lean' or 'Fat', fed diets containing either FO or a VO blend. Diet principally affected 
metabolism genes, mainly of lipid and carbohydrate, followed by immune response genes. 
Genotype had a much lower impact on metabolism-related genes and affected mostly 
signalling pathways. Replacement of dietary FO by VO caused an up-regulation of long-chain 
polyunsaturated fatty acid biosynthesis, but there was a clear genotype effect as fatty acyl 
elongase (elovl2) was only up-regulated and desaturases (∆5fad and ∆6fad) showed a higher 
magnitude of response in Lean fish, which was reflected in liver fatty acid composition. Fatty 
acid synthase (FAS) was also up-regulated by VO and the effect was independent of 
genotype. Genetic background of the fish clearly affected regulation of lipid metabolism, as 
PPARα and PPARβ were down-regulated by the VO diet only in Lean fish, while in Fat 
salmon SREBP-1 expression was up-regulated by VO. In addition, all three genes had a lower 
expression in the Lean family group than in the Fat, when fed VO. Differences in muscle 
adiposity between family groups may have been caused by higher levels of hepatic fatty acid 
and glycerophospholipid synthesis in the Fat fish, as indicated by the expression of FAS, 1-
acyl-sn-glycerol-3-phosphate acyltransferase and lipid phosphate phosphohydrolase 2. 
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Conclusions: This study has identified metabolic pathways and key regulators that may 
respond differently to alternative plant-based feeds depending on genotype. Further studies 
are required but data suggest that it will be possible to identify families better adapted to 
alternative diet formulations that might be appropriate for future genetic selection 
programmes. 
 
Background 
Fish are highly nutritious components of the human diet. In addition to providing high quality 
and easily digested protein, vitamins and minerals, they are particularly important in being the 
main source of essential n-3 long-chain polyunsaturated fatty acids (LC-PUFA). The 
beneficial effects of these fatty acids, such as eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), include prevention of a range of cardiovascular and 
inflammatory diseases, and neurological disorders [1]. With catches from commercial 
fisheries stagnating since 2001, aquaculture is supplying an increasing proportion of fish for 
human consumption, estimated at around 50 % of total supply in 2008 [2]. However, the 
expansion of aquaculture and the demands it makes upon resources provide many challenges, 
leading to questions concerning the sustainability of this activity. In particular, marine and 
salmonid aquaculture relies heavily on fish meal (FM) and fish oil (FO), obtained from wild 
fishery stocks, for the production of fish feeds and around 88.5% of the total global 
production of FO is currently used by aquaculture [3]. The increasing scarcity of FO supplies 
will seriously limit aquaculture growth, and the future of this activity therefore strongly 
depends on reducing its reliance on FO by seeking to replace them with alternative, largely 
terrestrial, oils. Vegetable oils (VO) represent a potentially critical resource in this respect. 
However, VO lack the n-3 LC-PUFA which are abundant in FO, and farming fish on diets 
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containing a high proportion of VO results in lower levels of these omega-3 fatty acids in 
flesh, compromising their health-promoting effects to the human consumer [4]. 
The use of selective breeding programs to enhance traits of commercial importance is 
becoming increasingly more common in aquaculture [5]. Combining genetic selection with 
changes in commercial feed formulations (i.e., higher levels of inclusion of VO) may be a 
viable strategy to meet worldwide demand for farmed fish without compromising animal 
welfare or nutritional value. Recently we showed that deposition and / or retention in flesh of 
dietary n-3 LC-PUFA, EPA and DHA, is a highly heritable trait in salmon [6], prompting 
further interest in exploring genotype-nutrient interactions. Other recent work has investigated 
potential interactions between genetic selection for body fatness and dietary lipid level in 
rainbow trout [7,8], and the effects of FM and / or FO replacement on the liver transcriptome 
of both rainbow trout and Atlantic salmon [9-11]. However, there are few data on the 
interaction between genotype and dietary fatty acid composition. In this respect, microarrays 
have great potential for application as hypothesis-generating tools. The objective of the 
present study was to investigate nutrient-genotype interactions in two groups of Atlantic 
salmon families, Lean and Fat, fed diets where FO was completely replaced by a VO blend. 
The knowledge gained concerning how this substitution affects hepatic metabolism and, 
furthermore, how these effects may depend on the genetic background of the fish, not only 
informs our understanding of lipid metabolism more generally but is also highly relevant to 
the strategy of genetic selection for families better adapted to alternative and more sustainable 
feed formulations in the future. A previous study has already focused on hepatic cholesterol 
and lipoprotein metabolism [12], which was shown to present a significant diet × genotype 
interaction, while here we will present more broadly the effects of the factors 'diet' and 
'genotype'.    
Results 
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Microarray results 
Two-way ANOVA of the cDNA microarray dataset returned a high number of features 
showing evidence of differential expression for each factor - 713 for diet and 788 for 
genotype – and hence a more detailed analysis was restricted to the top 100 most significant 
hits for each factor, which were then categorised according to function (excluding 33-35% 
non-annotated features) (Fig. 1). The functional category most affected by diet was that of 
metabolism (mainly lipid and carbohydrate metabolism), while immune response and 
intracellular trafficking were also affected. Within lipid metabolism, the affected genes are 
involved in PUFA, fatty acid and cholesterol biosynthesis (fatty acyl desaturases - ∆5fad and 
∆6fad, fatty acid synthase - FAS, squalene monooxygenase and possibly cytochrome P450 
reductase), glycerophospholipid metabolism (phospholipase D3) and acylglycerol 
homeostasis (angiopoietin-like 3). Some genes related to carbohydrate metabolism, implicated 
in glycolysis, glutamine/fructose 6-phosphate and glycerol-3-phosphate metabolism, such as 
alpha-enolase, glutamine-fructose-6-phosphate transaminase 1(GFPT1) and glycerol kinase, 
respectively, were also identified as being significantly affected by diet. Genotype had a lower 
impact on metabolism-related genes (primarily lipid and protein metabolism) and affected 
mostly genes involved in signalling. Regarding lipid metabolism, primary roles of affected 
genes are in glycerophospholipid metabolism (N-acylethanolamine-hydrolyzing acid amidase 
precursor, lipid phosphate phosphohydrolase 2 - LPP2 and 1-acyl-sn-glycerol-3-phosphate 
acyltransferase - AGPAT), fatty acid transport (intestinal fatty acid binding protein) and 
lipoprotein metabolism (apolipoprotein B – ApoB and endothelial lipase – EL). In addition, 
both factors had an effect on a relatively high number of transcription-related genes. Detailed 
lists of the top 100 most significant genes for diet and genotype, organised by biological 
function and including the normalised expression ratio between treatments, are shown in 
Tables 2 and 3, respectively. Gene Ontology enrichment analysis, which enables the 
identification of GO terms significantly enriched in the input entity list when compared to the 
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whole array dataset, was performed for both factors, providing evidence for which biological 
processes may be particularly altered in the experimental conditions being compared. For diet, 
seven significant GO terms, all interrelated, were identified: oxidoreductase activity, stearoyl-
CoA 9-desaturase activity, unsaturated fatty acid biosynthetic and metabolic processes, very 
long chain fatty acid (VLCFA) biosynthetic and metabolic processes. This is explained by the 
high number of ∆5fad and ∆6fad features that were significantly altered when dietary FO was 
replaced by VO (Table 2). In contrast, no GO terms were significantly enriched in the 
genotype list. 
RT-qPCR 
Quantification of gene expression by RT-qPCR was performed to partially validate the 
microarray results and to examine particular genes of interest in detail. The latter included 
several fatty acyl desaturase and elongase genes involved in the LC-PUFA biosynthesis 
pathway that were identified by GO analysis as being significantly affected by diet, as well as 
peroxisome proliferator-activated receptors (PPAR) and sterol regulatory element binding 
protein 1 (SREBP-1), which have important roles in regulating the expression of multiple 
lipid metabolism genes (Table 4). In spite of the generally low fold changes, a good 
correspondence in terms of expression ratios or in the direction of change (up- or down-
regulation), was obtained between the microarray and RT-qPCR results for most quantified 
genes, including ∆5fad and ∆6fad, FAS and heme oxygenase 1 (HOX) for the factor diet, and 
ApoB, LPP2 and AGPAT for the factor genotype (Tables 2-4). However, comparison of the 
microarray and RT-qPCR expression results show an inverse change in expression for GFPT1 
and glutathione S-transferase A (GST) in response to diet, the latter only in the Fat group, and 
of EL between family groups, although only when feeding on FO (where the fold-change in 
the microarray was negligible). Nonetheless, a perfect match was not expected given that RT-
qPCR primers were obtained either from published work (e.g., GST) or, when available, 
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designed on well characterized sequences such as GenBank reference sequences or clusters on 
the gene index database for Atlantic salmon (ASGI), which do not necessarily match exactly 
the clone on the array. In fact, in the case of EL there is evidence that the microarray probe 
has high similarity with multiple EST’s and hence is likely to have resulted in cross-
hybridisation [12], while the reference sequence for GFPT1 and the clone in the microarray 
are only 93% identical in the aligned region. 
In terms of regulation of gene expression by the factor diet, the qPCR results confirmed the 
significant up-regulation of ∆5fad and ∆6fad in fish fed VO, with a higher fold change being 
measured for ∆6fad. In addition, the expression ratio was higher in the Lean family group 
than in Fat fish, as had also been indicated in the microarray analysis. Of the elongase genes, 
only elovl2 was significantly up-regulated by the VO diet, but just in the Lean family group. 
Furthermore, quantification of PPAR genes revealed that only PPARα was down-regulated 
significantly when salmon were fed the VO diet, but only in the Lean family group. On the 
other hand, expression of SREBP-1 was only significantly affected in Fat fish, being up-
regulated in fish fed the VO diet. Other genes which were significantly and consistently 
regulated were FAS and EL (both up-regulated when VO replaced FO in the diet), while GST, 
HOX and AGPAT only showed significant regulation in Fat fish. Finally, comparison 
between the two family groups showed a significantly lower expression of ∆5fad, ∆6fad, 
PPARα, PPARβ, SREBP-1 and GST in the Lean group but only when fish were fed FO, in 
the case of fads, or when fed the VO diet, in the case of PPARs, SREBP-1 and GST. In 
addition, FAS was also significantly down-regulated in the Lean group, independent of diet. 
Liver fatty acid composition 
Fatty acid analysis of liver showed significant differences in all fatty acid classes related 
mostly to diet but also to genotype (except for total n-3 PUFA and total PUFA) (Table 5). The 
percentage of total n-6 PUFA (reflecting mainly 18:2n-6) was significantly increased when 
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VO replaced FO in the diet. Levels of total n-3 PUFA were, on the other hand, significantly 
higher in the FO treatments independent of genotype. For EPA and DHA there was a 
significant diet × genotype interaction, resulting from the fact that, when comparing Fat and 
Lean fish, higher levels of these LC-PUFA were found in the Fat family group when fed the 
FO diet but the inverse was observed when the same fish were fed the VO diet. 
Discussion 
In the present study we analysed the effects of diets containing high levels of plant proteins 
and with complete replacement of FO by VO on the liver transcriptome of Atlantic salmon, 
which is the primary metabolic organ of fish, as well as the influence of genotype on these 
responses. Here we focus on the separate effects of diet and genotype given that interactions, 
indicating pathways that were differentially affected by diet depending on the genetic 
background of the fish, were discussed in detail previously [12].  
A common methodological difficulty in this type of nutritional experiment is that effects 
are typically quite subtle although physiological and metabolic pathways can be impacted by 
even small fold changes in gene expression. This has been demonstrated by several studies 
[7,9,11] and by previously reported data from the present study showing that low fold changes 
in gene expression were associated with biochemical differences in tissue lipid class and 
apolipoprotein composition [12]. Furthermore, low fold changes observed in this study were 
generally corroborated by RT-qPCR, even if the low expression ratios meant that differences 
were not always significant. It should also be noted that a total match between the microarray 
and the RT-qPCR results is not expected due to the approach taken to design RT-qPCR 
primers on better annotated reference sequences rather than on less well characterized 
microarray clones. In view of the whole genome duplication event that occurred in salmonid 
fishes [13], transcriptomic and gene expression studies are often more challenging due to the 
presence of duplicated and highly similar genes whose transcripts might be differentially 
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regulated, as observed previously for lipoprotein lipase [12]. Therefore, collectively, and in 
conjunction with previous studies, data obtained in the present microarray study enabled 
identification of pathways that may be differentially affected by both dietary oil composition 
and genetic background related to flesh adiposity.      
Effects of diet on lipid metabolism 
Within the list of genes affected by diet, those involved in fatty acyl desaturation were 
prominent, leading to the identification, through GO enrichment analysis, of several terms 
related to LC-PUFA biosynthetic and metabolic processes. The up-regulation of ∆5fad and 
∆6fad in both family groups when dietary FO was replaced by VO was confirmed by RT-
qPCR. Several studies have previously demonstrated up-regulation of genes involved in LC-
PUFA biosynthesis in salmon when FO is replaced by VO [10,14,15]. RT-qPCR also 
confirmed previous work showing that elovl2 is responsive to dietary n-3 LC-PUFA levels 
[15], being the only elongase whose expression was up-regulated when FO was replaced by 
VO. However, a significant effect was only observed in the Lean family group. In addition, 
both microarray and RT-qPCR analyses indicated that the up-regulation of ∆5fad and ∆6fad 
showed a considerably higher fold-change in the Lean fish, due mainly to lower basal 
expression of fads in Lean salmon, compared to Fat, when fed FO. These results indicate that 
the activity of this biosynthetic pathway may be dependent on the genetics of the fish, with 
different family groups showing differences in the magnitude of response. The liver fatty acid 
composition revealed that differences in EPA and DHA levels between fish fed either diet 
were smaller in the Lean fish, due to higher n-3 LC-PUFA in fish fed VO and lower n-3 LC-
PUFA in fish fed FO, compared to the equivalent treatments in the Fat group. In addition, 
intermediates in the biosynthetic pathway, such as 20:4n-3 and 22:5n-3, tended to be present 
at higher levels in the Lean family group, suggesting that differences observed in the levels of 
mRNA of LC-PUFA biosynthesis genes, which have been shown to correlate with the 
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enzymatic activity of this pathway in salmon [16,17], were reflected in biochemical 
composition. 
Another lipid metabolism gene significantly affected by diet was FAS, which was up-
regulated in both family groups when fed VO. A well demonstrated effect of dietary FO 
supplementation in mammals is hypotriglyceridemia, resulting from a coordinated effect of n-
3 LC-PUFA in suppressing hepatic lipogenesis and enhancing fatty acid oxidation in liver and 
muscle [18]. Furthermore, this gene also appears to be regulated at a pre-translational level 
and hence changes in FAS transcription are likely to result in important effects in terms of 
enzyme activity [19]. Similar mechanisms are believed to operate in fish but, although 
reduced hepatic lipogenic activity modulated by LC-PUFA has been demonstrated in vitro 
[20], a direct relationship with dietary FO and VO has not always been clear in vivo [21,22]. 
The regulation of FAS in response to FO replacement by VO did not show an interaction with 
the flesh leanness/fatness phenotype in this study, as might have been expected. This was 
because genotype also had a significant effect, with the Lean group having lower levels of 
FAS expression than the Fat fish, with a similar fold-change in both diets. 
Regulation of lipid metabolism is complex and controlled by several transcription factors 
and nuclear receptors, including PPARs and SREBPs. SREBP-1c is a major regulator of 
lipogenesis in mammals [18]. Here we measured the expression of SREBP-1 as there is no 
evidence for the existence of alternatively spliced isoforms in salmon, and primers 
corresponded to an identical region in mammalian SREBP-1a and SREBP-1c [23]. Our results 
agree with Minghetti et al. [23], who showed SREBP-1 was increased by cholesterol and 
decreased by EPA and DHA supplementation in a salmon cell line, denoting a similar 
nutritional regulation to mammals [18]. However, there was a clear genetic effect as 
expression of SREBP-1 was 3-fold higher in Fat salmon fed VO, containing lower EPA, DHA 
and cholesterol, than in fish fed FO, whereas no regulation was observed in the Lean group. 
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PPARs have been less studied in fish than in mammals but present evidence suggests 
PPARα and PPARβ have similar ligands and functions to their mammalian homologues, 
while PPARγ may present some functional differences [24,25]. LC-PUFA are well recognised 
enhancers of PPARα activity in fish, and while the response of PPARβ to LC-PUFA might be 
variable between fish species, an enhancement of activity in sea bass, plaice and sea bream 
[24-26] and of expression in Atlantic salmon [27] has been observed. In addition, and unlike 
rodents, PPARα and PPARβ have a similar pattern of expression in response to fasting and 
feeding in sea bream liver, indicating that they may be regulated similarly [25]. In the present 
study, PPARα was down-regulated when VO replaced FO but only in the Lean family group 
and, although not statistically significant, PPARβ showed a similar trend, suggesting similar 
transcriptional regulation of these nuclear receptors by dietary fatty acid composition. These 
results thus indicate that the genetic background of the fish might affect PPAR transcriptional 
responses to LC-PUFA. In contrast, no nutritional regulation was observed for PPARγ 
transcription in liver, in accordance with previous studies in fish, including salmon, and its 
predominant role in adipocytes [24,28]. 
The hypotriglyceridemic effects of n-3 LC-PUFA in mammals involve activation of 
PPARα, leading to up-regulation of β-oxidation genes (including carnitine 
palmitoyltransferase I - CPT1 and acyl-CoA oxidase - ACO) and suppression of SREBP-1c 
transcription that down-regulates lipogenic enzymes [29,30]. As previously reported, FAS 
expression was up-regulated in both family groups fed the VO diet but neither CPT1 nor ACO 
expression, was affected [12]. As elovl2 expression was only altered in the Lean fish and both 
∆5fad and ∆6fad showed greater up-regulation in Lean salmon fed VO, we may speculate 
that PPARα (and potentially also PPARβ) expression may be involved in down-regulation of 
LC-PUFA biosynthesis. Paradoxically, fatty acyl desaturases are regulated by both SREBPs 
and PPARs in mammals [31]. In addition, PPARα agonists regulate the transcriptional 
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activity of elongases in rat, although only elovl5 and not elovl2 [32]. However, in mammals, 
PPARα ligands induce the transcription of elongases and desaturases while we observed an 
up-regulation of elovl2 and a stronger stimulation of ∆5fad and ∆6fad transcription when 
PPARα expression was lower. In the rat and human ∆6fad gene promoters, both PUFA and 
PPARα response regions have been identified which suppress and induce, respectively, ∆6fad 
expression [33]. The molecular mechanisms of transcriptional regulation of these genes are 
complex and will require further investigation in salmon [34]. In contrast, target genes of 
SREBP-1 remain elusive and, although it may regulate FAS expression [23], this was only 
observed in Fat fish whereas, in the Lean group, another mechanism is required to explain up-
regulation of FAS in VO-fed fish as expression of SREBP-1 was unaffected. Nonetheless, the 
action of SREBP-1 is under the regulation of liver X receptor (LXR) and these complex 
pathways have only recently started to be investigated in fish [23]. 
Another gene affected by diet was squalene epoxidase (SQLE), which was up-regulated by 
VO but only markedly in the Lean family group. This enzyme catalyses the first oxygenation 
step in sterol biosynthesis, a pathway identified earlier as presenting a diet × genotype 
interaction [12]. In contrast, cytochrome P450 reductase (CPR) was down-regulated in salmon 
fed VO, particularly in Lean fish. This enzyme has multiple roles as the electron donor for 
several oxygenase enzymes, such as cytochrome P450 (involved in drug and xenobiotic 
metabolism, and sterol and bile acid synthesis), HOX and cytochrome b5 (which supports 
both sterol and LC-PUFA biosynthesis pathways). In addition, it has key roles in the 
biosynthesis of several signalling factors and the regulation of oxidative response genes 
[reviewed by 35]. CPR is transcriptionally regulated by PPARα in mouse and, given the 
comparable PPARα and CPR expression in Lean salmon fed VO, similar regulation likely 
occurs in salmon. However, changes in CPR expression can be related to several processes 
that were affected by FO replacement. Thus, CPR expression could be linked to changes in 
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both cholesterol and LC-PUFA biosynthesis, both more marked in Lean fish, although this is 
unlikely because VO induced up-regulation of these pathways. A more likely association is 
with cell oxidant metabolism, also suggested by the microarray results as being possibly 
down-regulated in VO-fed fish. In particular, down-regulation of HOX in salmon fed VO, 
more marked for Lean fish correlating with CPR expression, might be an indication of this. 
Effect of diet on carbohydrate and intermediate metabolism 
Within the metabolism genes that were identified by the microarray analysis as being 
significantly affected by dietary oil substitution, a few relate to carbohydrate metabolism, 
particularly glucose and intermediary metabolism. Given that similar effects were observed in 
previous salmonid studies, and that a few signal transduction genes present in the list of diet 
significant effects are also potentially implicated in these pathways, these results warrant 
further discussion, even if the observed fold changes were low. An association between lipid 
and carbohydrate metabolism in salmon is not surprising given that the pathways of 
lipogenesis, lipolysis, glycolysis, gluconeogenesis and pentose phosphate shunt are all 
interrelated in the regulation of body energy homeostasis. In mammals, the role of LC-PUFA 
as “fuel partitioners” involves both directing fatty acids away from anabolic and towards 
catabolic routes as well as enhancing glucose flux to glycogen, mediated by effects on 
SREBP-1 and transcription factors that regulate key genes of lipid metabolism and glycolysis 
[30]. Similar mechanisms may operate in fish but differences are likely given that carnivorous 
fish like salmon have low capacity to use carbohydrate and appear to show features of glucose 
intolerance [36,37]. Nonetheless, dietary n-3/n-6 ratio has been shown to influence mRNA 
levels of the glucose transporter GLUT4 in Atlantic salmon muscle, with some reflection in 
plasma glucose [38]. In addition to a decreased hexokinase and phosphoenolpyruvate 
carboxykinase expression, complete replacement of FM and FO by vegetable alternatives in 
rainbow trout resulted in a slightly increased expression of glycerol kinase, as observed here 
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[11]. This enzyme is at the intersection of lipid-carbohydrate metabolism and over-expression 
of this gene in human muscle and rat hepatoma cells resulted in higher TAG synthesis and up-
regulation of the pentose phosphate pathway providing reducing power for lipogenesis [39]. 
Panserat et al. [11] hypothesised that the up-regulation of glycerol kinase may be related to 
higher lipid biosynthesis in liver when trout were fed plant-based diets. Similarly, our results, 
associated with the observed changes in FAS mRNA when VO replaced FO, suggest a 
possible relationship with lipogenesis. Also possibly related with this was the up-regulation of 
two different biotinidase clones with the potential to increase availability of substrates for 
FAS and/or gluconeogenesis in VO-fed fish. This gene, besides being involved in the 
regulation of gene expression, including genes of glucose metabolism, codes for an enzyme 
that recycles biotin, which is a co-factor for several carboxylases responsible for production 
of substrates for lipogenesis and gluconeogenesis [40]. 
Another gene affected by diet was alpha-enolase, which was slightly down regulated in 
Lean fish fed VO. A similar effect was observed in liver of salmon fed rapeseed oil in 
comparison to FO [9]. This glycolytic enzyme participates in the conversion of glucose to 
pyruvate, a key intermediate at the intersection of multiple metabolic pathways, including 
lipogenesis. Thus, this might result in lower levels of pyruvate for conversion to acetyl-CoA 
in VO-fed fish. This result does not necessarily conflict with an increase in lipogenesis given 
that, in fish, carbon skeletons for de novo fatty acid production are mainly derived from amino 
acid catabolism rather than from carbohydrates, whose main contribution towards lipogenesis 
is to supply NADPH via the pentose-phosphate pathway [37].  
Finally, a few signalling genes that were significantly affected by diet might also have an 
effect on glucose metabolism, assuming that similar cascades exist in fish. One of these is 
phosphoinositide 3-protein kinase (PI3K), which mediates insulin’s effects on glucose, lipid 
and protein metabolism, and that was significantly down regulated in VO-fed fish. Among 
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other roles, it regulates glucose cellular uptake in mammals, recruiting GLUT4 transporters to 
the cell surface [41]. In addition, it is found upstream of a signal transduction cascade 
regulating glycogen synthesis through glycogen synthase, by inactivating glycogen synthase 
kinase-3 (GSK3) [41,42]. In our study, expression of GSK3-binding protein (GBP) was 
significantly increased in VO-fed Lean fish. GBP is a protein that blocks GSK3, which in turn 
inactivates glycogen synthase [43]. Hence, it is possible that the oil composition of the diet 
might also affect glucose metabolism and glycogen storage. 
Effect of diet on oxidative stress and immune response 
Increased oxidative stress associated with the consumption of FO has been typically reported 
in fish and mammals [27,44,45]. Accordingly, genes related to oxidant metabolism were 
found in the significant list for diet. A thioredoxin domain-containing protein, possessing an 
antioxidant role [46], and GST, which detoxifies peroxidised lipids and xenobiotics [47], were 
down-regulated in salmon fed VO, consistent with the higher auto-oxidative potential of LC-
PUFA in FO. However, quantification of GST by RT-qPCR was not consistent with the 
microarray result, although the possibility exists that different GST genes with differential 
regulation exist in salmon and this requires clarification. In addition, the observed down-
regulation of HOX in VO-fed fish, validated by RT-qPCR, might be related to a decrease in 
oxidative stress in these fish. This enzyme catalyses the degradation of heme and can be 
induced by oxidative stress [48] and may be increased during pro-inflammatory states, being 
thought to increase resistance to oxidative injury and ameliorate inflammation [49]. The n-3 
LC-PUFA in FO have important anti-inflammatory actions in mammals [50], which does not 
correlate with the expression of HOX and its putative role in inflammation in this case. 
Inflammation is an important mechanism in immune defence but, in fish, the demonstrated 
effects of LC-PUFA on immune and inflammatory mechanisms have been inconsistent [45]. 
However, a recent study has clearly shown an effect of dietary oil composition on the 
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progression of a myxosporean parasite infection in Gilthead sea bream, with fish fed the VO 
diet showing higher signs of the disease and faster course of infection in comparison with 
those on a FO diet [51].On the other hand, the synthesis of pro-inflammatory eicosanoids was 
increased in the intestine of salmon fed vegetable-based diets in response to acute stress [52]. 
In the present study immune response was the second highest category of genes affected by 
diet, after metabolism. Whether this is due to the potential anti-inflammatory role of dietary 
FO or whether VO diets can have detrimental health effects is not clear as the fold-changes 
were subtle, as expected in unchallenged animals. Nonetheless, the majority of genes related 
to processes of both innate and adaptive immunity were up-regulated in fish fed VO. Only T-
cell and leukotriene B4 (LTB4) receptors, that are reduced after antigen and LTB4 exposure, 
respectively, and, in the case of LTB4 receptor, increased after EPA administration [53-55], 
were down-regulated in salmon fed VO. 
Differences in gene expression between Lean and Fat genotypes 
Muscle adiposity is a trait of great importance in animal production, aquaculture included, and 
hence physiological changes induced by genetic selection for this phenotype have been 
examined in various animals, including rainbow trout [7,8]. In the present study the main 
differences between family groups were associated with signal transduction pathways, 
followed by metabolism. Only a small number of lipid metabolism genes varied in relation to 
muscle adiposity, as reported previously in rainbow trout, where the main differences were 
related to lipogenesis and mitochondrial oxidative metabolism [7,8]. In our study 
glycerophospholipid metabolism may have been down-regulated in the Lean family group 
through AGPAT and LPP2, two enzymes acting consecutively on de novo TAG and 
phospholipid biosynthesis [56,57]. Quantification of AGPAT and LPP2 expression by RT-
qPCR confirmed this down-regulation but fold-changes were too subtle to be significant. 
AGPAT converts lysophosphatidic acid into phosphatidic acid (PA), while LPP2 then 
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catalyzes the conversion of PA to diacylglycerol. All these molecules can function as second 
messengers and are involved in the regulation of multiple signalling pathways. Therefore, 
down-regulation of this pathway in the Lean group has the potential to lower lipid 
biosynthesis, at least partly explaining the flesh lipid phenotype, but may also alter levels of 
lipid signalling molecules. On the other hand, differences in muscle adiposity might also be 
caused by higher hepatic “de novo” fatty acid synthesis in the Fat family group, as indicated 
by the expression of FAS. In a previous study, no differences were found in the expression of 
ACO and CPT1, which suggested that the phenotypes could not be explained by differences 
in β-oxidation [12]. By contrast, in rainbow trout Fat and Lean families, β-oxidation and 
mitochondrial oxidative metabolism, but not lipogenesis, were affected by genetic selection 
[7], although another study using the same trout lines suggested differences related to 
lipogenesis rather than fatty acid oxidation [8]. Thus, both metabolic processes are likely 
involved and discrepancies in the data are likely due to lack of methodological sensitivity to 
detect the small fold-changes that are possibly characteristic of these biological processes and 
typical in this type of experiment. 
PPARα, PPARβ and SREBP-1 were also regulated in response to genotype, being down-
regulated in Lean fish, but only when fed the VO diet. In cobia, Rachycentron canadum, a 
negative correlation was found between PPARα mRNA levels in liver and body lipid 
deposition [58]. Furthermore, PPARβ appears to play a similar role in fish to that in 
mammals, as a ubiquitous regulator of fat burning and with a role in energy mobilisation 
during early development [24,25]. Therefore, both PPARα and PPARβ might have a role in 
the control of adipogenesis in fish and it may be the case that, similarly to chickens [59], Fat 
salmon might have higher lipid turnover than their Lean counterparts when fed a diet that 
predisposes for hepatic fat deposition, even though the end result is higher lipid accumulation 
in liver [60]. To explain this, Collin et al. [59] suggested that a fat chicken family is better 
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“equipped” to deal with higher circulating levels of TAG when fed a high fat diet, compared 
to lean chicken. On the other hand, we observed a direct relationship between SREBP-1 and 
FAS expression in the Fat family group in response to diet, as well as in VO-fed fish in 
response to genotype. It thus appears that SREBP-1 may be partly responsible for higher 
lipogenesis in Fat fish, compared to Lean, when fed VO. 
Conclusions 
This study has enabled the identification of metabolic pathways and key regulators that may 
respond differently to more sustainable diets, in which FO is replaced by VO, depending on 
genotype, thus confirming the potential of microarrays as hypothesis-generating tools, even in 
these nutritional studies where changes in gene expression are quite subtle. Collectively, and 
in conjunction with previous studies, the data indicate that dietary lipid composition may 
potentially affect glucose, glycogen storage and intermediary metabolism, in addition to 
lipogenesis, supporting a role for LC-PUFA in “fuel partitioning” in fish as well as in 
mammals. Therefore, more integrative studies investigating the effects of dietary VO on 
energy homeostasis are required. However, important genotype-related differences may also 
exist in the regulation of metabolism. In terms of lipid metabolism, expression of LC-PUFA 
and lipid biosynthesis genes, as well as of key regulator transcriptional factors, was 
differentially affected by diet depending on the genetic background of the fish. Although 
further studies are required, the present data indicate that it will be possible to identify 
families better adapted to alternative diet formulations that might be appropriate for future 
genetic selection programmes. 
Methods 
Feeding trial and sampling 
A dietary trial was conducted using two genetically characterised and contrasting groups of 
farmed Atlantic salmon post-smolts, comprising full-sib families selected from the Landcatch 
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Natural Selection Ltd (LNS) breeding program (Argyll, Scotland). The choice of the two 
family groups was based on estimated breeding values (EBVs) of the parents for high or low 
flesh adiposity, assessed by Torry Fatmeter (Distell Industries, West Lothian, UK), a trait that 
was found to have a heritability ranging from 0.17 to 0.39 in this dataset. The two groups 
were created from four unrelated full-sib families; two families from the extreme lower end of 
the EBV distribution for flesh lipid content ('Lean') and two families from the extreme upper 
end of the distribution ('Fat'). The average EBV for the lipid content of the two Fat families 
was 2.00 percentage units higher than that of the two selected Lean families, representing a 
standardised selection differential of 2.33 standard deviations. Assessment of the flesh and 
viscera lipid content at the end of the feeding trial confirmed differences in adiposity between 
the two genotypes, in spite of an interaction with diet being also found [12]. 
Two thousand fish of each group were stocked into eight 12 x 5m3 net pens at the Ardnish 
Fish Trials Unit (Marine Harvest Scotland, Lochailort, Highland; 500 fish pen-1). Duplicate 
pens from each group of fish were fed one of two experimental diets (Skretting ARC, 
Stavanger, Norway) containing 32-25% fish meal, 40-45% plant meals and 27.5-30% oil 
supplied either as northern fish oil (FO) or as a vegetable oil (VO) blend comprising rapeseed, 
palm and Camelina oils in a ratio of 5:3:2 [12]. Diets were formulated to fully satisfy the 
nutritional requirements of salmonid fish [61] and contained similar levels of PUFA (around 
31%) but different n-3 and n-6 PUFA contents, 25.3% and 4.6% in the FO diet and 13.4% and 
17.1% in the VO diet, respectively. Further details including full diet formulations, proximate 
and fatty acid compositions of the feeds can be found in Bell et al. [60]. 
After 55 weeks on the experimental diets 25 fish were sampled per pen. The fish were 
killed by a blow to the head following anaesthesia using MS222, 24 h after the last meal. 
Samples of liver were immediately frozen on dry ice and stored at -70ºC for molecular and 
fatty acid analyses. 
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RNA extraction and purification 
Liver tissue (0.2 g) from six individuals per experimental group was rapidly homogenised in 
2mL of TRI Reagent (Ambion, Applied Biosystems, Warrington, U.K.) using an Ultra-Turrax 
tissue disrupter (Fisher Scientific, Loughborough, U.K.) and stored at –70 ºC. Total RNA was 
later isolated, following manufacturer’s instructions, and RNA quality (integrity and purity) 
and quantity was assessed by gel electrophoresis and spectrophotometry (NanoDrop ND-
1000, Thermo Scientific, Wilmington, U.S.A.). One hundred micrograms of total RNA from 
each individual sample was further cleaned by mini spin-column purification (RNeasy Mini 
Kit, Qiagen, Crawley, UK), and then re-quantified and quality assessed as above. 
Microarray hybridizations and image analysis 
The TRAITS/SGP (v.2.1) salmon 17k cDNA microarray, described in detail by Taggart et al. 
[10], was used in this experiment (ArrayExpress accession: A-MEXP-1930). A dual-label 
experimental design was employed for the microarray hybridisations. Each experimental 
sample was competitively hybridised against a common pooled-reference sample, which 
comprised equal amounts of all samples used in the study. This design permits valid statistical 
comparisons across all treatments to be made. The entire experiment comprised 24 
hybridisations - 2 genotypes (Lean/Fat) × 2 diets (FO/VO) × 6 biological replicates. 
An indirect labelling methodology was employed in preparing the microarray targets. 
Antisense amplified RNA (aRNA) was produced from 500 ng of purified total RNA per 
sample using the Amino Allyl MessageAmpTM II aRNA Amplification Kit (Ambion, 
Applied Biosystems), as per manufacturer’s instructions, followed by Cy3 or Cy5 fluor 
incorporation mediated by a dye-coupling reaction, as previously described in detail [12]. 
Experimental samples and the pooled reference sample (batch reaction) were labelled with 
Cy3 and Cy5 dye suspension stocks (PA23001 or PA25001, GE HealthCare, Little Chalfont, 
UK), respectively.  Unincorporated dye was removed by column purification (Illustra 
AutoSeq G-50 spin columns; GE Healthcare). Dye incorporation and aRNA yield were 
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quantified by spectrophotometry (NanoDrop ND-1000) and further quality controlled by 
separating 0.4 µL of the sample through a thin mini-agarose gel and visualising products on a 
fluorescence scanner (Typhoon Trio, GE Healthcare). 
Microarray hybridisations were performed in a Lucidea semi-automated system (GE 
Healthcare), without a pre-hybridisation step. For hybridisation of each array, each labelled 
biological replicate and corresponding pooled reference (40 pmol each dye, c. 150 ng aRNA) 
were combined and added to the hybridisation solution, comprising 185 µL 0.7X UltraHyb 
buffer (Ambion), 20 µL poly(A) at l0 mg/mL (Sigma-Aldrich, Dorset, UK), 10 µL herring 
sperm at c. 10 mg/mL (Sigma-Aldrich) and 10 µL ultra pure BSA at 10 mg/mL (Sigma-
Aldrich), as detailed previously [12]. Two post-hybridisation automatic washes followed by 
six manual washes to a final stringency of 0.1× SSC (EasyDipTM Slide staining system; 
Canemco Inc., Quebec, Canada) were performed before scanning. 
Scanning was performed at 10 µm resolution using an Axon GenePix 4200AL Scanner 
(MDS Analytical Technologies, Wokingham, Berkshire, U.K.) with laser power constant 
(80%) and “auto PMT” enabled to adjust PMT for each channel such that less than 0.1% of 
features were saturated and that the mean intensity ratio of the Cy3 and Cy5 signals was close 
to one. BlueFuse software (BlueGnome, Cambridge, U.K.) was then used to identify features 
and extract fluorescence intensity values from the resultant TIF images. Following a manual 
spot removal procedure and fusion of duplicate spot data (BlueFuse proprietary algorithm), 
the resulting fluorescence intensity data and quality annotations for the 17,102 gene features, 
were exported into the GeneSpring GX version 10.0.2 analysis platform (Agilent 
Technologies, Wokingham, Berkshire, U.K.) after undergoing a block Lowess normalisation. 
Data transformation and quality filtering were then performed and all control features were 
excluded from subsequent analyses [12]. This returned a list of 14,772 genes eligible for 
statistical analysis. Experimental annotation complied fully with minimum information about 
 22
a microarray experiment (MIAME) guidelines [62]. The experimental hybridisations and 
further methodological details are archived on the EBI ArrayExpress database 
(http://www.ebi.ac.uk/arrayexpress/) under accession number E-TABM-1089. 
RT-qPCR 
Expression of selected genes was determined by reverse transcription quantitative real time 
PCR (RT-qPCR). Details on the target qPCR primer sequences are given in Table 1. In 
addition, amplification of three potential reference genes - cofilin-2, elongation factor-1α (elf-
1α) and β-actin - was performed. However, only cofilin-2 expression proved to be sufficiently 
stable across treatments for normalisation of the results. Cofilin-2 had been established in a 
previous salmon cDNA microarray study as a suitable reference gene on the basis of constant 
expression between FO and VO based feeds over a wide range of time points ('unidentified 
liver EST', [10]).  
For RT-qPCR, 1 µg of column-purified total RNA per sample was reverse transcribed into 
cDNA using the VersoTM cDNA kit (ABgene, Surrey, U.K.), following manufacturer’s 
instructions, using a mixture of random hexamers (400ng/µL) and anchored oligo-dT 
(500ng/µL) at 3:1 (v/v). Negative controls (containing no enzyme) were performed to check 
for genomic DNA contamination. A similar amount of cDNA was pooled from all samples 
and the remaining cDNA was then diluted 20-fold with water. RT-qPCR analysis used 
relative quantification with the amplification efficiency of the primer pairs being assessed by 
serial dilutions of the cDNA pool. qPCR amplifications were carried out in duplicate 
(Quantica, Techne, Cambridge, U.K.) in a final volume of 20 µL containing either 5 µL or 2 
µL (for the reference genes and HOX) diluted (1/20) cDNA, 0.5 µM of each primer and 10 
µL AbsoluteTM QPCR SYBR® Green mix (ABgene). Amplifications were carried out with a 
systematic negative control (NTC-non template control). The qPCR profiles contained an 
initial activation step at 95 °C for 15 min, followed by 30 to 40 cycles (depending on target): 
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15 s at 95 °C, 15 s at the specific primer pair annealing temperature (Ta; Table 1) and 15 s at 
72 °C. After the amplification phase, a melt curve of 0.5 °C increments from 75 ºC to 90 °C 
was performed, enabling confirmation of the amplification of a single product in each 
reaction. RT-qPCR product sizes were checked by agarose gel electrophoresis and the identity 
of amplicons of newly designed primers (FAS, GFPT1, HOX, LPP2 and AGPAT) was 
confirmed by sequencing.  
Lipid extraction and fatty acid analyses 
Total lipids from six fish per treatment were extracted and determined gravimetrically from 1-
2 g of liver by Ultra Turrax homogenisation in 20 volumes of chloroform/methanol (2:1 v/v) 
[63]. Fatty acid methyl esters (FAME) were prepared by acid-catalysed transesterification of 
total lipids [64]. Following purification, FAME were separated and quantified by gas-liquid 
chromatography using a Thermo Fisher Trace GC 2000 (Thermo Fisher, Hemel Hempstead, 
UK) equipped with a fused silica capillary column (ZB wax, 30 m×0.32 mmi.d.; 
Phenomenex, Macclesfield, UK) with hydrogen as carrier gas and using on-column injection. 
The temperature gradient was from 50 to 150 °C at 40 °C/min and then to 195 °C at 1.5 
°C/min and finally to 220 °C at 2 °C/min. Individual methyl esters were identified by 
comparison with known standards. Data were collected and processed using the Chromcard 
for Windows (version 2.00) computer package (Thermoquest Italia S.p.A., Milan, Italy). 
Statistical analysis 
Microarray hybridisation data were analysed in GeneSpring GX version 10.0.2 (Agilent 
Technologies) by two-way ANOVA, which examined the explanatory power of the variables 
‘diet’ and ‘genotype’ (diet×genotype interaction presented in [12]), followed by Gene 
Ontology (GO) enrichment analysis, at a significance level of 0.05. No multiple test 
correction was employed as previous analyses, confirmed by RT-qPCR, indicate that such 
corrections are over-conservative for this type of data [14]. Gene expression results assessed 
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by RT-qPCR were analysed by the ∆∆Ct method using the relative expression software tool 
(REST 2008, http://www.gene-quantification.info/), employing a pair wise fixed reallocation 
randomisation test (10,000 randomisations) with efficiency correction [65], to determine the 
statistical significance of expression ratios between two treatments. Finally, significant 
differences in liver fatty acid composition were determined by means of two-way ANOVA, at 
a significance level of p<0.05, using the Graphpad Prism™ (version 4.0) statistical package 
(Graphpad Software, San Diego, CA).  
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Table 2 Liver transcripts corresponding to the top 100 most significant features 
exhibiting differential expression between diets. Annotated features (65% of all clones) are 
arranged by categories of biological function and, within these, by decreasing significance 
(assessed by two-way ANOVA). Also indicated are the GenBank accession numbers for each 
clone (or, when not available, the probe number is given instead) and the expression ratio 
between fish fed VO and those fed FO, for each genotype (Lean and Fat).   
 
Accession or Gene VO/FO ANOVA 
probe number   Lean Fat p-value 
Metabolism    
 
 Lipid metabolism 
   
can_D6D_S1B04 Delta-6 fatty acyl desaturase 2.8 1.9 <0.0001 
can_D6D_S1B03 Delta-6 fatty acyl desaturase 2.1 1.4 <0.0001 
can_D5D_S1B01 Delta-5 fatty acyl desaturase 2.3 1.5 <0.0001 
can_D6O_S1B06 Delta-6 fatty acyl desaturase 2.0 1.4 <0.0001 
CK887422 Delta-6 fatty acyl desaturase 2.0 1.8 <0.0001 
EG647320 Delta-6 fatty acyl desaturase 1.8 1.4 0.0001 
CK876943 Fatty acid synthase 1.4 1.6 0.0002 
can_D5D_S1B02 Delta-5 fatty acyl desaturase 2.1 1.2 0.0003 
CK894344 Phospholipase D3 - 1.1 - 1.2 0.0006 
EG647463 Cytochrome P450 reductase - 1.4 - 1.1 0.0017 
liv_lrr_01F07 Angiopoietin-like 3 1.2 1.4 0.0020 
can_D5O_S1B05 Delta-6 fatty acyl desaturase 1.5 1.2 0.0045 
CK879648 Squalene monooxygenase   1.9 1.1 0.0058 
 
Protein and amino acid metabolism 
CK893821 Sequestosome 1or ubiquitin-binding protein P62 - 1.3 - 1.1 0.0022 
CK884400  Kynureninase (L-kynurenine hydrolase) 1.3 1.2 0.0065 
 
Carbohydrate metabolism 
   
int_oss_T4F08 Alpha-enolase putative  - 1.2 - 1.0 0.0007 
liv_lrr_01A06 Glutamine-fructose-6-phosphate transaminase 1 1.2 1.8 0.0032 
CO470771 Glycerol kinase 1.1 1.1 0.0062 
 
Xenobiotic and oxidant metabolism 
AJ425332 Thioredoxin domain-containing protein 8 - 1.3 - 1.3 0.0024 
EG355339 Glutathione S-transferase A - 1.4 - 1.4 0.0036 
 
Transport/ intracellular trafficking 
CK886667 Na/K ATPase  1.5 1.1 <0.0001 
CN181143 Coatomer subunit alpha 1.2 1.4 0.0004 
DW588711 Synaptic vesicle glycoprotein 2B 1.1 1.1 0.0004 
CK894482 Taurine transporter - 1.3 - 1.3 0.0019 
CK887866 ABC-type branched-chain amino acid transport systems 
ATPase component 
1.2 1.1 0.0022 
CO470399 Sodium/potassium-transporting - 1.2 - 1.2 0.0044 
EG647422 Transferrin  - 1.2 - 1.1 0.0047 
EG648286 ATP-binding cassette sub-family B member 10, 
mitochondrial 
1.2 1.3 0.0055 
 37
mitochondrial 
AM083913 Chromatin modifying protein 2a  - 1.3 - 1.2 0.0068 
 
Regulation of transcription 
   
CK894063 Zinc finger protein 183 - 1.5 - 1.3 0.0003 
CK890154 Butyrate response factor 2 1.5 1.1 0.0043 
EG648112 Retrovirus-related Pol polyprotein 1.1 1.3 0.0046 
CK885196 CCAAT/enhancer binding protein delta1 1.2 1.2 0.0052 
CK890573 MADS box protein AP1b 1.2 1.2 0.0053 
CK883722 Y-box binding protein  1.1 1.3 0.0067 
 
Translation 
   
AM402452 Phenylalanyl-tRNA synthetase, alpha subunit 1.4 1.9 0.0022 
 
Signalling/Signal transduction 
   
CK886572 GSK-3-binding protein  1.9 1.0 0.0002 
CK892148 Growth factor receptor-bound protein 7 - 1.5 - 1.1 0.0028 
ova_opk_09K06 Phosphoinositide 3-protein kinase - 1.1 - 1.3 0.0031 
CK873849 Receptor-type tyrosine-protein phosphatase beta precursor  - 1.1 - 1.1 0.0036 
DW590775 Myozenin-1  1.6 1.5 0.0055 
 
Immune response 
   
EG647383 Human leukocyte antigen (HLA) class II histocompatibility 1.1 1.2 0.0008 
AM402762 Complement component C8 alpha chain 1.3 1.7 0.0018 
EG649410 D-dopachrome tautomerase  1.4 1.1 0.0019 
AJ425750 Non-histone chromosomal protein H6 1.1 1.3 0.0024 
CK884265 Ganglioside GM2 activator 1.3 1.1 0.0030 
AM402841 Complement component C8 alpha chain  1.5 2.1 0.0032 
CK886548 T cell receptor (TCR)-alpha/delta locus - 1.2 - 1.0 0.0041 
spl_sts_18A08 Leukotriene B4 receptor 1 putative - 1.4 - 1.1 0.0047 
CK880083 Interleukin-15 precursor 1.1 1.3 0.0067 
AJ425732 CD97 antigen isoform 2  1.2 1.1 0.0066 
 
Miscellaneous and unknown function 
   
CK897269 Biotinidase precursor  1.3 1.7 0.0002 
AM402518 Biotinidase  1.4 1.9 0.0006 
CK894173 EFHD2  (EF hand domain containing2) 1.2 1.1 0.0007 
kid_cki_A1E04 S100-A1 calcium binding 1.4 1.1 0.0009 
CO469646 beta B3-crystallin  - 1.1 - 1.0 0.0012 
CO469710 Transmembrane protein 30A - 1.1 - 1.2 0.0019 
AJ425502 Heme oxygenase 1 - 2.7 - 1.7 0.0024 
CK885237 EF-hand domain-containing protein D2 1.1 1.1 0.0026 
AJ425502 Heme oxygenase 1 - 2.6 - 1.4 0.0037 
DW588567 S100 calcium binding protein beta subunit 1.1 1.1 0.0042 
CK897725 Type-1 growth hormone  1.1 1.1 0.0053 
BM414485 Apoptosis-inducing factor mitochondrion-associated inducer 1.5 1.4 0.0054 
BM414504 Syndecan 2 - 1.2 - 1.1 0.0061 
BI468143 Anaphase-promoting complex subunit CDC26 - 1.3 - 1.3 0.0064 
CK885116 17-beta hydroxysteroid dehydrogenase 13  - 1.1 - 1.4 0.0065 
 
 
 
 
 38
Table 3 Liver transcripts corresponding to the top 100 most significant features 
exhibiting differential expression between family groups. Annotated features (67% of all 
clones) are arranged by categories of biological function and, within these, by decreasing 
significance (assessed by two-way ANOVA). Also indicated are the GenBank accession 
numbers for each clone (or, when not available, the probe number is given instead) and the 
expression ratio between Lean and Fat fish fed either FO or VO. 
Accession or Gene Lean/Fat ANOVA 
probe number   FO VO p-value 
Metabolism    
 
 Lipid metabolism 
   
CK889835 N-acylethanolamine-hydrolyzing acid amidase precursor - 1.4 - 1.2 0.0001 
can_Apo_S1A12 Apolipoprotein B - 1.4 - 1.1 0.0014 
BM414066 Endothelial lipase precursor   - 1.1 - 1.6 0.0015 
CK898924 Lipid phosphate phosphohydrolase 2 - 1.2 - 1.2 0.0017 
AJ425826 Intestinal fatty acid binding protein 1.1 1.2 0.0032 
CO470953 1-acyl-sn-glycerol-3-phosphate acyltransferase - 1.1 - 1.3 0.0040 
 
Energy metabolism/generation of precursor metabolites 
   
EG649459 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 1.2 1.2 0.0009 
 
Protein and amino acid metabolism 
CK900470 26S protease regulatory subunit 7 - 1.1 - 1.2 0.0020 
mus_mfo_15B08 Proteasome subunit alpha type-1 1.2 1.1 0.0021 
EG648604 Serine protease-like protein  1.0 1.4 0.0023 
CO470297 Transmembrane protease, serine 2 - 1.2 - 1.1 0.0032 
DW592216 Ubiquitin carboxyl-terminal hydrolase 5 - 1.1 - 1.1 0.0040 
 
Transport/ intracellular trafficking 
CK886667 Na/K ATPase  1.1 1.6 <0.0001 
CK884193 Polycystin-2 (Polycystic kidney disease 2 protein homolog) 1.1 1.2 0.0002 
CK890974 Mitochondrial solute carrier family 25 member 25 - 1.2 - 2.2 0.0002 
CK896189 Mitochondrial solute carrier family 25 member 25 - 1.3 - 2.3 0.0002 
CK880187 ATP-binding cassette sub-family B member 8, mitochondrial - 1.3 - 1.1 0.0011 
 
Regulation of transcription 
   
CK881770 Hematopoietically-expressed homeobox protein  - 1.1 - 1.6 0.0001 
CK888834 BTEB transcription factor - 1.4 - 1.5 0.0002 
CK895950 Transcription factor CP2-like - 1.2 - 1.6 0.0010 
CK884953 Nuclear transcription factor Y subunit beta - 1.2 - 1.1 0.0015 
CK888548 Rev protein - Human immunodeficiency virus 1 - 1.5 - 1.0 0.0019 
CK883410 Retinoic acid receptor gamma (nuclear receptor) - 1.1 - 1.1 0.0020 
int_rpk_78B12 Sp3 transcription factor  - 1.1 - 1.4 0.0035 
CK876044 Homeobox protein HoxB13 - 1.2 - 1.2 0.0041 
DW589427 Cullin-associated and neddylation-dissociated 1 (CAND1) 1.4 1.1 0.0044 
 
Translation 
   
AJ424434 Ribosome production factor 1 1.1 1.2 0.0002 
gil_oss_G6P11 40S ribosomal protein S23 1.3 1.3 0.0008 
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EG648403 60S ribosomal protein L7a 1.2 1.2 0.0013 
CK893177 40S ribosomal protein S26 1.1 1.2 0.0013 
DW591137 40S ribosomal protein S3a - 1.2 - 1.1 0.0024 
EG647811 60S ribosomal protein L7 1.1 1.1 0.0026 
EG648956 Eukaryotic translation initiation factor 1A 1.1 1.1 0.0033 
AJ424851 40S ribosomal protein S18 1.2 1.2 0.0034 
 
Signalling/Signal transduction 
   
CK884714 14-3-3 protein epsilon 1.1 1.1 0.0003 
EG648400 Guanine nucleotide binding protein (G protein) - 1.2 - 1.2 0.0004 
CK888542 Insulin-like growth factor binding protein 1  - 1.2 - 2.5 0.0008 
CK886572 GSK-3-binding protein putative  - 1.1 1.8 0.0009 
CK877143 Calpain-1  - 1.1 - 1.4 0.0010 
EG648399 PTC7 protein phosphatase homolog - 1.2 - 1.1 0.0016 
EG648333 Stathmin 1.1 1.2 0.0018 
CK898969 G-protein coupled receptor 37 - 1.1 - 1.1 0.0019 
DW589782 Amyloid beta (A4) precursor-like protein  1.1 1.2 0.0034 
CK898590 Mitogen-activated protein kinase kinase 4  - 1.0 - 1.2 0.0035 
CK897997 Calpastatin   - 1.1 - 1.1 0.0039 
AJ424385 Protein tyrosine phosphatase, receptor-type, zeta1 - 1.1 - 1.2 0.0041 
 
Structural proteins 
   
AJ425204 Tropomyosin-1 alpha (muscle contraction)  - 1.1 - 1.2 0.0031 
 
Immune response 
   
CK886548 T cell receptor (TCR)-alpha/delta locus - 1.1 - 1.2 0.0005 
CK894741 Complement factor D (adapsin) - 1.1 - 1.2 0.0007 
AM042439 Major histocompatibility complex (MHC) class I antigene - 1.3 - 1.4 0.0014 
kid_cki_A1G02 Interferon-inducible protein  - 1.2 - 1.4 0.0015 
CO471904 Major histocompatability complex (MHCI)  - 1.1 - 1.2 0.0019 
CK894557 Major histocompatability complex (MHCI)  - 1.2 - 1.1 0.0023 
AM042249 Major histocompatability complex (MHCI)  - 1.1 - 1.2 0.0025 
bra_opk_01B08  Scavenger receptor cysteine-rich gene - 1.3 - 1.6 0.0029 
CO469739 T-cell receptor(TCR)-alpha/delta locus - 1.1 - 1.1 0.0030 
AJ424124 Major histocompatibility complex (MHC class I) - 1.2 - 1.1 0.0037 
hrt_opk_07E23 Interferon alpha 1-like  - 1.1 - 1.1 0.0041 
 
Miscellaneous and unknown function 
   
CK898014 Protein fuzzy homolog - 1.1 - 1.2 0.0002 
kid_cki_A2A05 Cyclin B2 - 1.3 - 1.4 0.0006 
EG647643 Purine nucleoside phosphorylase - 1.1 - 2.0 0.0010 
liv_lrr_07B04 Nuclear protein 1  - 1.1 - 2.1 0.0028 
AM402622 Non-POU domain containing, octamer-binding - 1.7 - 1.4 0.0029 
EG648147 Adhesion-regulating molecule 1  - 1.2 - 1.1 0.0037 
BM414485 Apoptosis-inducing factor mitochondrion-associated inducer 1.4 1.5 0.0038 
DW589496 Cyclin-dependent kinase inhibitor - 1.2 - 1.3 0.0044 
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Table 4 Relative expression of genes assayed by RT-qPCR in liver of Atlantic salmon. 
Values are normalised (by cofilin-2) gene expression ratios between fish fed VO in relation to 
FO for each family group or of Lean fish in relation to the Fat group when fed either one of 
the diets. Values in bold are significantly different, at p<0.05 (REST 2008). 
    VO/FO   Lean/Fat 
  Lean  Fat  FO  VO 
Genes   Ratio p-value   Ratio p-value   Ratio p-value   Ratio p-value 
∆5fad  3.95 0.001  2.04 0.002  -2.33 0.009  -1.20 0.317 
∆6fad_a  8.27 0.000  4.52 0.004  -1.85 0.049  -1.02 0.942 
elovl5a  1.18 0.505  -1.03 0.817  -1.18 0.420  1.03 0.908 
elovl5b  1.57 0.184  1.05 0.758  -1.25 0.471  1.19 0.416 
elovl2  2.35 0.025  -1.04 0.841  -1.56 0.098  1.58 0.112 
FAS   1.76 0.005  2.11 0.003  -1.72 0.001  -2.04 0.011 
PPARα  -2.22 0.000  1.10 0.643  -1.16 0.358  -2.86 0.001 
PPARβ  -1.92 0.161  1.56 0.169  1.24 0.659  -2.44 0.002 
PPARγ  -1.10 0.828  -1.67 0.251  -2.00 0.214  -1.32 0.229 
SREBP-1  -1.16 0.761  3.32 0.004  1.82 0.332  -2.13 0.022 
GST  -1.18 0.412  1.40 0.010  1.29 0.210  -1.28 0.028 
HOX  -2.69 0.132  -1.82 0.013  1.83 0.271  1.24 0.120 
GFPT1  -1.33 0.244  -1.65 0.090  -1.18 0.619  1.05 0.783 
ApoB  1.40 0.443  1.84 0.152  -1.15 0.791  -1.52 0.076 
EL  3.52 0.034  8.57 0.002  1.38 0.494  -1.75 0.115 
LPP2  -1.33 0.506  -1.31 0.606  -1.22 0.754  -1.25 0.516 
AGPAT  1.40 0.375  1.42 0.041  -1.05 0.906  -1.07 0.574 
fad: fatty acyl desaturase (∆5 and ∆6);  elovl: elongase (three different transcripts); FAS: Fatty acid 
synthase; PPARs; peroxisome proliferator-activated receptors (three isoforms); SREBP-1: Sterol 
regulatory element binding protein-1; GST: glutathione S-transferase A; HOX: heme oxygenase 1; 
GFPT1: glutamine-fructose-6-phosphate transaminase 1; ApoB: apolipoprotein B; EL: endothelial 
lipase; LPP2: lipid phosphate phosphohydrolase 2; AGPAT: 1-acyl-sn-glycerol-3-phosphate 
acyltransferase. 
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Figure 1 Functional categories of genes differentially expressed in Atlantic salmon 
liver. The top 100 most significant clones (two-way ANOVA analysis; p<0.05) which 
were differentially expressed between the two diets (A) and family groups (B) were 
categorized according to biological function. Non-annotated clones, those representing 
the same gene or with a miscellaneous function (Tables 2 and 3) are not represented. 
 

